Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: WeirdPro Randy who wrote (1079)	3/6/1998 11:57:00 AM
From: cardiologist to be	Read Replies (1) \| Respond to of 1359

first of all an echocardiogram is not an ecg. an ecg is an electrocardiogram, costing about 50-75 buck plus interpretation. an echo can cost on the order of 250 bucks or so. my point was that the incidence of valvular disease with phen/fen is likely higher than reported and the scare is prompting a lot of unnecessary testing that will lead to further costs and likely litigation as some dufus doctors will say that valve damage from other causes (like RF, calcification, senile atrophy, etc) is due to phen fen. redux, while most likely blameless, will get sucked down into the mud with phen/fen and companies associated with it will suffer.